Sep 1, 2026 07:02AM
Aug 31, 2026 08:52AM
Aug 6, 2026 04:36PM
Aug 6, 2026 07:05AM
May 8, 2026 12:28PM
May 7, 2026 07:03AM
May 4, 2026 04:26PM Guggenheim Starts Aclaris Therapeutis (ACRS) at Buy
Apr 27, 2026 04:46PM
Apr 16, 2026 06:40AM
Apr 15, 2026 07:21AM
Mar 19, 2026 06:59AM
Mar 16, 2026 06:50AM
Feb 27, 2026 09:05AM
Feb 26, 2026 07:46AM Aclaris Therapeutics (ACRS) Misses Q4 EPS by 1c
Jan 30, 2026 08:58AM
Jan 28, 2026 06:44AM
Jan 27, 2026 06:56AM
Jan 6, 2026 03:20PM
Dec 19, 2025 04:01PM
Nov 6, 2025 08:14AM
Oct 15, 2025 07:13AM Cantor Fitzgerald Reiterates Overweight Rating on Aclaris Therapeutis (ACRS): 2026 Rich in Catalysts
Aug 7, 2025 08:35AM
Jul 29, 2025 04:02PM
Jul 28, 2025 08:45AM
Jul 9, 2025 04:36PM
Jun 30, 2025 09:32AM
Jun 25, 2025 06:42AM
Jun 9, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Aclaris Therapeutis (ACRS)
Jun 2, 2025 07:02AM
May 28, 2025 07:06AM
May 28, 2025 07:05AM
May 14, 2025 07:52AM
May 8, 2025 04:31PM
Apr 29, 2025 07:02AM
Apr 22, 2025 06:59AM Aclaris Therapeutics (ACRS) Secures U.S. Food and Drug Administration IND Clearance for ATI-052
Mar 7, 2025 07:06AM
Feb 27, 2025 07:02AM
Feb 12, 2025 06:51AM
Jan 30, 2025 04:04PM
Dec 23, 2024 06:46AM
Dec 19, 2024 04:34PM
Nov 20, 2024 03:46PM Cantor Fitzgerald Upgrades Aclaris Therapeutis (ACRS) to Overweight
Nov 19, 2024 11:07AM
Nov 19, 2024 07:19AM
Nov 19, 2024 02:35AM
Nov 19, 2024 02:34AM
Nov 18, 2024 02:54PM
Nov 18, 2024 12:34PM
Nov 18, 2024 08:11AM Aclaris Therapeutics (ACRS) Announces 35.56M Share Offering at $2.25/sh
Nov 18, 2024 08:10AM

456,885 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All